FAMOTIDINE 20MG

FAMOTIDINE 20MG was reported 369 times

FAMOTIDINE 20MG is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TUMOUR NECROSIS FACTOR RECEPTOR-ASSOCIATED PERIODIC SYNDROME 1 0.0167
1 LUNG ASSIST DEVICE THERAPY 1 0.0161
2 DISSOCIATIVE FUGUE 1 0.0149
3 GASTRIC PNEUMATOSIS 1 0.0141
4 PRODUCT STERILITY LACKING 1 0.0119
5 ORAL VIRAL INFECTION 1 0.0088
6 RHABDOMYOSARCOMA 1 0.0053
7 IRIS HYPERPIGMENTATION 1 0.0048
8 PANCREATIC CARCINOMA RECURRENT 1 0.0041
9 HYPOAESTHESIA EYE 2 0.0034
10 GASTRIC MUCOSA ERYTHEMA 1 0.0030
11 DRUG EFFECT FASTER THAN EXPECTED 1 0.0030
12 AMINO ACID LEVEL DECREASED 1 0.0030
13 VASCULAR DEVICE OCCLUSION 1 0.0029
14 HEMIPLEGIC MIGRAINE 1 0.0029
15 PORTAL VENOUS GAS 1 0.0028
16 ERYTHROMELALGIA 1 0.0027
17 COLON CANCER STAGE III 1 0.0026
18 VULVAL ABSCESS 1 0.0024
19 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 2 0.0022
20 MANUFACTURING ISSUE 1 0.0022
21 BLADDER OBSTRUCTION 1 0.0019
22 DEVICE MAINTENANCE ISSUE 1 0.0017
23 URINARY TRACT INFECTION PSEUDOMONAL 1 0.0017
24 ACTIVITIES OF DAILY LIVING DECREASED 1 0.0016
25 NUTRITIONAL CONDITION ABNORMAL 1 0.0014
26 INFUSION SITE INFLAMMATION 1 0.0014
27 BITE 1 0.0014
28 FINGER AMPUTATION 1 0.0014
29 SOFT TISSUE INJURY 1 0.0013
30 MALIGNANT ASCITES 1 0.0013
31 LABORATORY TEST INTERFERENCE 1 0.0013
32 SYSTEMIC LUPUS ERYTHEMATOSUS RASH 1 0.0013
33 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT 1 0.0012
34 PERIORBITAL PAIN 1 0.0012
35 ALLERGIC SINUSITIS 1 0.0012
36 TONGUE PRURITUS 1 0.0012
37 INFUSION SITE NODULE 1 0.0010
38 BLADDER CATHETERISATION 1 0.0010
39 PRODUCT CLOSURE REMOVAL DIFFICULT 1 0.0010
40 CORONAVIRUS TEST POSITIVE 1 0.0010
41 SINUSITIS BACTERIAL 1 0.0009
42 GALLBLADDER ENLARGEMENT 1 0.0009
43 INFUSION SITE BRUISING 2 0.0009
44 INFUSION SITE MASS 1 0.0009
45 ORAL SURGERY 2 0.0009
46 INFUSION SITE WARMTH 1 0.0008
47 POST-ACUTE COVID-19 SYNDROME 1 0.0008
48 ADENOCARCINOMA PANCREAS 1 0.0008
49 HYPERTONIC BLADDER 2 0.0007
50 BILIARY DILATATION 1 0.0007
51 INTELLECTUAL DISABILITY 1 0.0007
52 INJECTION SITE PARAESTHESIA 1 0.0007
53 BRONCHIAL DISORDER 1 0.0006
54 TINEA PEDIS 1 0.0006
55 AORTIC VALVE DISEASE 1 0.0006
56 SHOULDER FRACTURE 1 0.0006
57 MUCOUS STOOLS 3 0.0006
58 TONSILLECTOMY 1 0.0006
59 MALIGNANT PLEURAL EFFUSION 1 0.0006
60 EROSIVE OESOPHAGITIS 1 0.0006
61 BILIARY DYSKINESIA 1 0.0006
62 INFUSION SITE DISCHARGE 1 0.0006
63 UTERINE SPASM 1 0.0005
64 AURA 1 0.0005
65 RADIOTHERAPY 1 0.0005
66 GALLBLADDER INJURY 1 0.0005
67 CARDIAC DISCOMFORT 1 0.0005
68 EYELID PAIN 1 0.0005
69 RENAL HAEMORRHAGE 1 0.0005
70 VASCULAR STENT THROMBOSIS 1 0.0005
71 PULSELESS ELECTRICAL ACTIVITY 2 0.0005
72 TONGUE DISCOMFORT 2 0.0005
73 REACTION TO DRUG EXCIPIENTS 1 0.0005
74 CONTRAST MEDIA REACTION 1 0.0004
75 URINARY TRACT OBSTRUCTION 1 0.0004
76 TRANSPLANT 1 0.0004
77 DEVICE INFUSION ISSUE 1 0.0004
78 LACTOSE INTOLERANCE 1 0.0004
79 TONSILLITIS 2 0.0004
80 MULTIPLE ALLERGIES 3 0.0004
81 STEATORRHOEA 1 0.0004
82 FOOD POISONING 2 0.0004
83 ANAESTHETIC COMPLICATION 1 0.0004
84 CHONDROPATHY 1 0.0004
85 ABNORMAL FAECES 3 0.0004
86 NERVE INJURY 4 0.0004
87 PANCREATIC CARCINOMA METASTATIC 1 0.0004
88 OESOPHAGEAL STENOSIS 1 0.0004
89 UPPER RESPIRATORY TRACT CONGESTION 1 0.0003
90 EMERGENCY CARE 1 0.0003
91 ISCHAEMIC CARDIOMYOPATHY 1 0.0003
92 CHOLANGITIS 2 0.0003
93 INFUSION SITE SWELLING 2 0.0003
94 FOREIGN BODY IN THROAT 1 0.0003
95 TESTICULAR PAIN 1 0.0003
96 AUTOIMMUNE DISORDER 3 0.0003
97 HOSPICE CARE 3 0.0003
98 SKIN INJURY 1 0.0003
99 PEPTIC ULCER 1 0.0003
100 THROMBOPHLEBITIS 1 0.0003
101 HANGOVER 1 0.0003
102 DEPRESSIVE SYMPTOM 1 0.0003
103 SEASONAL ALLERGY 4 0.0003
104 SCLERODERMA 1 0.0003
105 LIVER TRANSPLANT 1 0.0003
106 THERAPY CESSATION 14 0.0003
107 RHINOVIRUS INFECTION 1 0.0003
108 MUSCLE RUPTURE 1 0.0003
109 ORAL INFECTION 1 0.0003
110 PROSTATOMEGALY 1 0.0003
111 NAIL DISCOLOURATION 1 0.0003
112 SUSPECTED COUNTERFEIT PRODUCT 1 0.0003
113 SKIN PAPILLOMA 1 0.0002
114 FUNGAL SKIN INFECTION 1 0.0002
115 HOMICIDAL IDEATION 1 0.0002
116 SMALL INTESTINAL OBSTRUCTION 3 0.0002
117 INFUSION SITE ERYTHEMA 2 0.0002
118 ABSCESS LIMB 1 0.0002
119 FACIAL PARALYSIS 2 0.0002
120 ABNORMAL SENSATION IN EYE 1 0.0002
121 PSYCHOLOGICAL TRAUMA 2 0.0002
122 LIGAMENT RUPTURE 1 0.0002
123 GALLBLADDER DISORDER 4 0.0002
124 MENINGITIS ASEPTIC 1 0.0002
125 HAEMOGLOBIN INCREASED 1 0.0002
126 ROSACEA 1 0.0002
127 SKIN ABRASION 1 0.0002
128 FOOT FRACTURE 4 0.0002
129 MEDICATION RESIDUE PRESENT 1 0.0002
130 HYPERVOLAEMIA 1 0.0002
131 ABDOMINAL TENDERNESS 1 0.0002
132 AMMONIA INCREASED 1 0.0002
133 PRODUCT COLOUR ISSUE 1 0.0002
134 CACHEXIA 1 0.0002
135 TEMPERATURE INTOLERANCE 2 0.0002
136 FAILURE TO THRIVE 1 0.0002
137 BLOOD LACTIC ACID INCREASED 1 0.0002
138 JOINT DISLOCATION 2 0.0002
139 ANORECTAL DISCOMFORT 1 0.0002
140 INJECTION SITE DISCHARGE 1 0.0002
141 BRUXISM 1 0.0002
142 HYDROCEPHALUS 1 0.0002
143 DRUG LEVEL BELOW THERAPEUTIC 1 0.0002
144 CYSTIC FIBROSIS 1 0.0002
145 DERMATITIS CONTACT 2 0.0002
146 MICTURITION URGENCY 2 0.0002
147 EXERCISE TOLERANCE DECREASED 1 0.0002
148 HERPES VIRUS INFECTION 1 0.0002
149 ENTEROCOLITIS 1 0.0002
150 SOCIAL AVOIDANT BEHAVIOUR 1 0.0002
151 DECREASED INTEREST 1 0.0002
152 PLEURISY 1 0.0002
153 WRIST FRACTURE 2 0.0002
154 HEARING IMPAIRED 1 0.0002
155 TYPE 1 DIABETES MELLITUS 1 0.0002
156 GANGRENE 1 0.0002
157 HEPATITIS B 1 0.0002
158 APHASIA 5 0.0002
159 INGUINAL HERNIA 1 0.0002
160 CYTOPENIA 2 0.0002
161 SPINAL OPERATION 2 0.0002
162 PRE-EXISTING CONDITION IMPROVED 1 0.0002
163 MULTIPLE INJURIES 1 0.0002
164 INFUSION SITE PAIN 2 0.0002
165 HERNIA 3 0.0002
166 CARDIAC FLUTTER 1 0.0002
167 HERPES SIMPLEX 1 0.0002
168 BRADYPHRENIA 1 0.0002
169 ORAL CANDIDIASIS 2 0.0002
170 WALKING AID USER 1 0.0002
171 PRODUCT FORMULATION ISSUE 1 0.0002
172 CHOLECYSTITIS CHRONIC 1 0.0001
173 METASTASES TO LYMPH NODES 1 0.0001
174 ULCER HAEMORRHAGE 1 0.0001
175 EYE MOVEMENT DISORDER 1 0.0001
176 ECCHYMOSIS 1 0.0001
177 FEELING DRUNK 1 0.0001
178 HYDRONEPHROSIS 1 0.0001
179 PAROSMIA 1 0.0001
180 LYMPHOMA 2 0.0001
181 CONCUSSION 1 0.0001
182 TORSADE DE POINTES 1 0.0001
183 CYANOSIS 2 0.0001
184 DRUG SCREEN POSITIVE 1 0.0001
185 HEAD INJURY 4 0.0001
186 CYSTITIS 4 0.0001
187 SENSORY DISTURBANCE 2 0.0001
188 RHINITIS 1 0.0001
189 MUSCLE DISORDER 1 0.0001
190 NEURALGIA 3 0.0001
191 ESCHERICHIA INFECTION 1 0.0001
192 SPINAL COMPRESSION FRACTURE 1 0.0001
193 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
194 INADEQUATE ANALGESIA 1 0.0001
195 METRORRHAGIA 2 0.0001
196 PSEUDOMONAS INFECTION 1 0.0001
197 BLOOD MAGNESIUM DECREASED 1 0.0001
198 MUSCLE STRAIN 1 0.0001
199 SKIN SWELLING 1 0.0001
200 COLD SWEAT 2 0.0001
201 IMMUNOSUPPRESSION 1 0.0001
202 GASTROINTESTINAL INFECTION 1 0.0001
203 GASTROENTERITIS VIRAL 2 0.0001
204 OPTIC NEURITIS 1 0.0001
205 UROSEPSIS 1 0.0001
206 HEPATIC STEATOSIS 2 0.0001
207 BACTERIAL INFECTION 2 0.0001
208 FLANK PAIN 1 0.0001
209 EYE PAIN 6 0.0001
210 RECALLED PRODUCT ADMINISTERED 1 0.0001
211 EYE INFLAMMATION 1 0.0001
212 HYPERSOMNIA 3 0.0001
213 POST PROCEDURAL COMPLICATION 2 0.0001
214 LOWER LIMB FRACTURE 2 0.0001
215 DIZZINESS POSTURAL 1 0.0001
216 COELIAC DISEASE 1 0.0001
217 KNEE OPERATION 1 0.0001
218 BLOOD PRESSURE ABNORMAL 2 0.0001
219 BRAIN INJURY 1 0.0001
220 GASTROOESOPHAGEAL REFLUX DISEASE 8 0.0001
221 LACRIMATION INCREASED 3 0.0001
222 EMPHYSEMA 1 0.0001
223 EAR DISCOMFORT 1 0.0001
224 SKELETAL INJURY 1 0.0001
225 TRANSFUSION 1 0.0001
226 JOINT INJURY 2 0.0001
227 BODY HEIGHT DECREASED 1 0.0001
228 IRRITABLE BOWEL SYNDROME 2 0.0001
229 RECTAL HAEMORRHAGE 4 0.0001
230 SKIN LACERATION 1 0.0001
231 BACK INJURY 1 0.0001
232 PRODUCT PRESCRIBING ISSUE 2 0.0001
233 PULMONARY THROMBOSIS 1 0.0001
234 OESOPHAGITIS 1 0.0001
235 CHOLELITHIASIS 3 0.0001
236 FUNGAL INFECTION 3 0.0001
237 HEPATOTOXICITY 2 0.0001
238 ORAL PAIN 2 0.0001
239 NEPHROPATHY TOXIC 1 0.0001
240 OCULAR DISCOMFORT 1 0.0001
241 EYE INFECTION 1 0.0001
242 FLATULENCE 5 0.0001
243 METASTASES TO LUNG 1 0.0001
244 UNINTENTIONAL MEDICAL DEVICE REMOVAL 1 0.0001
245 VASCULITIS 1 0.0001
246 SPLENOMEGALY 1 0.0001
247 SURGERY 5 0.0001
248 COVID-19 PNEUMONIA 1 0.0001
249 CHOLECYSTITIS 1 0.0001
250 ACCIDENT 1 0.0001
251 INFECTION 12 0.0001
252 LOCALISED INFECTION 2 0.0001
253 NOCTURIA 1 0.0001
254 HYPOPHAGIA 2 0.0001
255 HEPATITIS 2 0.0001
256 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
257 DIPLOPIA 2 0.0001
258 ANHEDONIA 2 0.0001
259 IMMUNE SYSTEM DISORDER 1 0.0001
260 PULMONARY CONGESTION 1 0.0001
261 EAR INFECTION 2 0.0001
262 THROAT TIGHTNESS 2 0.0001
263 NEUROPATHY PERIPHERAL 7 0.0001
264 IMPAIRED GASTRIC EMPTYING 1 0.0001
265 ACUTE HEPATIC FAILURE 1 0.0001
266 OSTEOPOROSIS 3 0.0001
267 INJECTION SITE ERYTHEMA 9 0.0001
268 ORAL DISCOMFORT 1 0.0001
269 HUNGER 1 0.0001
270 ROAD TRAFFIC ACCIDENT 3 0.0001
271 APHONIA 1 0.0001
272 MASS 1 0.0001
273 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
274 THERAPY INTERRUPTED 5 0.0001
275 RED BLOOD CELL COUNT DECREASED 2 0.0001
276 SUBDURAL HAEMATOMA 1 0.0001
277 IMPAIRED QUALITY OF LIFE 1 0.0001
278 PRODUCT SUBSTITUTION ISSUE 4 0.0001
279 PARAESTHESIA ORAL 1 0.0001
280 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
281 GASTROENTERITIS 1 0.0001
282 SINUSITIS 7 0.0001
283 ASCITES 2 0.0001
284 BRONCHITIS 5 0.0001
285 URINARY INCONTINENCE 2 0.0001
286 WHEEZING 4 0.0001
287 PULMONARY MASS 1 0.0001
288 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
289 THROAT IRRITATION 3 0.0001
290 BLOOD POTASSIUM DECREASED 2 0.0001
291 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
292 DISCOMFORT 4 0.0001
293 INSURANCE ISSUE 1 0.0001
294 TINNITUS 3 0.0001
295 FEELING HOT 4 0.0001
296 THYROID DISORDER 1 0.0001
297 LIMB DISCOMFORT 2 0.0001
298 DELUSION 1 0.0001
299 BRAIN FOG 1 0.0001
300 ULCER 1 0.0001
301 SCIATICA 1 0.0001
302 ABSCESS 1 0.0001
303 HYPOTHYROIDISM 2 0.0001
304 NIGHT SWEATS 2 0.0001
305 DYSPEPSIA 6 0.0001
306 PHOTOSENSITIVITY REACTION 1 0.0001
307 VIRAL INFECTION 2 0.0001
308 CHILLS 7 0.0001
309 INJECTION SITE PRURITUS 4 0.0001
310 SCAR 1 0.0001
311 GASTRIC DISORDER 2 0.0001
312 ILLNESS 6 0.0001
313 MUSCULOSKELETAL DISCOMFORT 1 0.0001
314 LOCAL SWELLING 1 0.0001
315 MUSCULOSKELETAL PAIN 3 0.0001
316 BURNING SENSATION 4 0.0001
317 METASTASES TO LIVER 1 0.0001
318 HYPOXIA 2 0.0001
319 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
320 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
321 OSTEOMYELITIS 1 0.0001
322 END STAGE RENAL DISEASE 1 0.0001
323 ANAPHYLACTIC REACTION 3 0.0001
324 THINKING ABNORMAL 1 0.0001
325 MIDDLE INSOMNIA 1 0.0001
326 OXYGEN SATURATION DECREASED 3 0.0001
327 PHOTOPHOBIA 1 0.0001
328 DYSARTHRIA 2 0.0001
329 BLOOD URINE PRESENT 1 0.0001
330 GASTRIC ULCER 1 0.0001
331 INJECTION SITE SWELLING 4 0.0001
332 LETHARGY 3 0.0001
333 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
334 EYE IRRITATION 3 0.0001
335 HOSPITALISATION 8 0.0001
336 SEROTONIN SYNDROME 1 0.0001
337 DRUG INTOLERANCE 5 0.0001
338 DYSTONIA 1 0.0001
339 HAEMORRHOIDS 1 0.0001
340 PLASMA CELL MYELOMA 2 0.0001
341 CHOKING 1 0.0001
342 SKIN FISSURES 1 0.0001
343 VISION BLURRED 7 0.0001
344 KIDNEY INFECTION 1 0.0001
345 SINUS DISORDER 1 0.0001
346 COUGH 14 0.0000
347 STOMATITIS 3 0.0000
348 EXTRA DOSE ADMINISTERED 2 0.0000
349 TASTE DISORDER 1 0.0000
350 PRODUCT PREPARATION ERROR 1 0.0000
351 INJECTION SITE WARMTH 1 0.0000
352 RIB FRACTURE 1 0.0000
353 ABDOMINAL PAIN UPPER 10 0.0000
354 DRUG DOSE OMISSION 8 0.0000
355 INTENTIONAL DRUG MISUSE 1 0.0000
356 DERMATITIS 1 0.0000
357 WITHDRAWAL SYNDROME 2 0.0000
358 OSTEOARTHRITIS 2 0.0000
359 IMPAIRED WORK ABILITY 1 0.0000
360 LIVER FUNCTION TEST INCREASED 1 0.0000
361 POOR QUALITY SLEEP 1 0.0000
362 SKIN CANCER 1 0.0000
363 FAECES DISCOLOURED 1 0.0000
364 AMNESIA 3 0.0000
365 PRODUCT DOSE OMISSION 3 0.0000
366 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
367 MELAENA 1 0.0000
368 NEOPLASM MALIGNANT 3 0.0000
369 GLOSSODYNIA 1 0.0000
370 RASH PAPULAR 1 0.0000
371 MULTIPLE SCLEROSIS RELAPSE 3 0.0000
372 SKIN DISCOLOURATION 2 0.0000
373 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
374 PERICARDIAL EFFUSION 1 0.0000
375 INJURY 3 0.0000
376 PRODUCT USE ISSUE 8 0.0000
377 MIGRAINE 4 0.0000
378 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
379 CONTUSION 4 0.0000
380 CONSTIPATION 9 0.0000
381 FIBROMYALGIA 1 0.0000
382 URINARY TRACT INFECTION 7 0.0000
383 LIVER INJURY 1 0.0000
384 ENCEPHALOPATHY 1 0.0000
385 ABASIA 1 0.0000
386 DYSGEUSIA 3 0.0000
387 DRY EYE 2 0.0000
388 HALLUCINATION 3 0.0000
389 PRODUCT COMPLAINT 1 0.0000
390 HAEMATEMESIS 1 0.0000
391 FLUSHING 4 0.0000
392 FLUID RETENTION 2 0.0000
393 DRUG RESISTANCE 1 0.0000
394 BACK PAIN 9 0.0000
395 SKIN ULCER 1 0.0000
396 RESPIRATORY TRACT INFECTION 1 0.0000
397 MUCOSAL INFLAMMATION 1 0.0000
398 SEDATION 1 0.0000
399 SPEECH DISORDER 2 0.0000
400 INCORRECT DOSE ADMINISTERED BY DEVICE 1 0.0000
401 ARTHRITIS 3 0.0000
402 PARAESTHESIA 6 0.0000
403 RENAL FAILURE 5 0.0000
404 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
405 PAIN 23 0.0000
406 FEAR 1 0.0000
407 JAUNDICE 1 0.0000
408 CONFUSIONAL STATE 6 0.0000
409 OEDEMA 2 0.0000
410 INFLUENZA LIKE ILLNESS 3 0.0000
411 MEMORY IMPAIRMENT 5 0.0000
412 DIVERTICULITIS 1 0.0000
413 FALL 12 0.0000
414 ABDOMINAL DISCOMFORT 6 0.0000
415 TARDIVE DYSKINESIA 1 0.0000
416 ANXIETY 10 0.0000
417 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
418 NEEDLE ISSUE 1 0.0000
419 DYSSTASIA 1 0.0000
420 LABORATORY TEST ABNORMAL 1 0.0000
421 GASTROINTESTINAL DISORDER 3 0.0000
422 ADVERSE DRUG REACTION 3 0.0000
423 EMOTIONAL DISTRESS 4 0.0000
424 INJECTION SITE RASH 1 0.0000
425 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
426 CHEST PAIN 6 0.0000
427 HYPERSENSITIVITY 6 0.0000
428 WEIGHT DECREASED 9 0.0000
429 FATIGUE 25 0.0000
430 CARDIAC DISORDER 3 0.0000
431 DRUG-INDUCED LIVER INJURY 1 0.0000
432 HIP FRACTURE 1 0.0000
433 DIARRHOEA 20 0.0000
434 RHINORRHOEA 2 0.0000
435 PNEUMONIA 10 0.0000
436 DEEP VEIN THROMBOSIS 2 0.0000
437 PAIN IN EXTREMITY 9 0.0000
438 IMPAIRED HEALING 1 0.0000
439 OSTEONECROSIS 1 0.0000
440 EYE DISORDER 1 0.0000
441 STAPHYLOCOCCAL INFECTION 1 0.0000
442 HEART RATE INCREASED 3 0.0000
443 DECREASED APPETITE 7 0.0000
444 TREMOR 5 0.0000
445 INSOMNIA 8 0.0000
446 DEHYDRATION 4 0.0000
447 SYNCOPE 3 0.0000
448 GAIT INABILITY 1 0.0000
449 MYALGIA 5 0.0000
450 HEPATIC ENZYME INCREASED 2 0.0000
451 DELIRIUM 1 0.0000
452 RASH MACULAR 1 0.0000
453 PLATELET COUNT DECREASED 3 0.0000
454 PRODUCT ADHESION ISSUE 1 0.0000
455 SKIN BURNING SENSATION 2 0.0000
456 MOBILITY DECREASED 2 0.0000
457 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
458 MYELOSUPPRESSION 1 0.0000
459 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000
460 VOMITING 13 0.0000
461 DRUG EFFECT INCOMPLETE 1 0.0000
462 PANIC ATTACK 1 0.0000
463 HEADACHE 17 0.0000
464 SEPSIS 3 0.0000
465 HYPOAESTHESIA 4 0.0000
466 ASTHMA 3 0.0000
467 HOT FLUSH 2 0.0000
468 UNEVALUABLE EVENT 2 0.0000
469 RHEUMATOID ARTHRITIS 3 0.0000
470 COLITIS 1 0.0000
471 CONDITION AGGRAVATED 8 0.0000
472 BLOOD PRESSURE INCREASED 4 0.0000
473 GAIT DISTURBANCE 5 0.0000
474 SEIZURE 3 0.0000
475 PERIPHERAL SWELLING 4 0.0000
476 ALOPECIA 5 0.0000
477 DISEASE PROGRESSION 3 0.0000
478 NAUSEA 20 0.0000
479 DISORIENTATION 1 0.0000
480 INJECTION SITE BRUISING 2 0.0000
481 THROMBOSIS 2 0.0000
482 JOINT SWELLING 3 0.0000
483 SOMNOLENCE 5 0.0000
484 DRY MOUTH 2 0.0000
485 DYSKINESIA 1 0.0000
486 BLINDNESS 1 0.0000
487 NEUTROPHIL COUNT DECREASED 1 0.0000
488 LUNG NEOPLASM MALIGNANT 1 0.0000
489 CARDIAC ARREST 2 0.0000
490 VISUAL IMPAIRMENT 3 0.0000
491 DIZZINESS 12 0.0000
492 POLLAKIURIA 1 0.0000
493 CARDIO-RESPIRATORY ARREST 1 0.0000
494 RENAL FAILURE ACUTE 1 0.0000
495 HYPERHIDROSIS 3 0.0000
496 BALANCE DISORDER 2 0.0000
497 PSORIASIS 3 0.0000
498 DYSPNOEA 13 0.0000
499 INTENTIONAL PRODUCT MISUSE 2 0.0000
500 MALAISE 10 0.0000
501 LIVER DISORDER 1 0.0000
502 TACHYCARDIA 2 0.0000
503 PULMONARY OEDEMA 1 0.0000
504 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
505 PRODUCT QUALITY ISSUE 3 0.0000
506 SKIN IRRITATION 1 0.0000
507 ARRHYTHMIA 1 0.0000
508 PULMONARY EMBOLISM 2 0.0000
509 DISEASE RECURRENCE 1 0.0000
510 COMA 1 0.0000
511 PRODUCTIVE COUGH 1 0.0000
512 RASH ERYTHEMATOUS 1 0.0000
513 MULTIPLE SCLEROSIS 1 0.0000
514 DEATH 18 0.0000
515 PRURITUS 8 0.0000
516 HYPOGLYCAEMIA 1 0.0000
517 PRODUCT DOSE OMISSION ISSUE 6 0.0000
518 PYREXIA 7 0.0000
519 HYPOTENSION 4 0.0000
520 HAEMOGLOBIN DECREASED 2 0.0000
521 INFLAMMATION 1 0.0000
522 ARTHRALGIA 8 0.0000
523 ABDOMINAL DISTENSION 2 0.0000
524 ECZEMA 1 0.0000
525 PANCREATITIS 1 0.0000
526 HYPERTENSION 4 0.0000
527 BRADYCARDIA 1 0.0000
528 DISTURBANCE IN ATTENTION 1 0.0000
529 RASH PRURITIC 1 0.0000
530 TREATMENT NONCOMPLIANCE 1 0.0000
531 HAEMATOCHEZIA 1 0.0000
532 ARTHROPATHY 1 0.0000
533 NECK PAIN 1 0.0000
534 BLISTER 1 0.0000
535 HYPONATRAEMIA 1 0.0000
536 MUSCULAR WEAKNESS 2 0.0000
537 CONVULSION 1 0.0000
538 ABDOMINAL PAIN 4 0.0000
539 PALPITATIONS 2 0.0000
540 BONE PAIN 1 0.0000
541 NASAL CONGESTION 1 0.0000
542 CATARACT 1 0.0000
543 FEELING ABNORMAL 4 0.0000
544 IRRITABILITY 1 0.0000
545 ILL-DEFINED DISORDER 1 0.0000
546 OEDEMA PERIPHERAL 2 0.0000
547 NASOPHARYNGITIS 3 0.0000
548 SWELLING FACE 1 0.0000
549 DEVICE DIFFICULT TO USE 1 0.0000
550 INFUSION RELATED REACTION 1 0.0000
551 DRY SKIN 2 0.0000
552 INJECTION SITE REACTION 1 0.0000
553 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
554 RASH 6 0.0000
555 WEIGHT INCREASED 3 0.0000
556 EPISTAXIS 1 0.0000
557 ASTHENIA 5 0.0000
558 ACNE 1 0.0000
559 CHRONIC KIDNEY DISEASE 1 0.0000
560 DIABETES MELLITUS 1 0.0000
561 INJECTION SITE PAIN 4 0.0000
562 CARDIAC FAILURE 1 0.0000
563 PROSTATE CANCER 1 0.0000
564 PRODUCT USE IN UNAPPROVED INDICATION 3 0.0000
565 TREATMENT FAILURE 1 0.0000
566 RENAL IMPAIRMENT 1 0.0000
567 SKIN EXFOLIATION 1 0.0000
568 CEREBROVASCULAR ACCIDENT 2 0.0000
569 PRODUCT STORAGE ERROR 1 0.0000
570 COVID-19 2 0.0000
571 DRUG WITHDRAWAL SYNDROME 1 0.0000
572 DEVICE ISSUE 1 0.0000
573 SUICIDAL IDEATION 1 0.0000
574 MUSCLE SPASMS 2 0.0000
575 ADVERSE EVENT 1 0.0000
576 BREAST CANCER 1 0.0000
577 SWELLING 1 0.0000
578 BLOOD GLUCOSE INCREASED 2 0.0000
579 DYSPHAGIA 1 0.0000
580 OFF LABEL USE 9 0.0000
581 ATRIAL FIBRILLATION 1 0.0000
582 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
583 DRUG INEFFECTIVE 13 0.0000
584 CHEST DISCOMFORT 1 0.0000
585 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
586 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
587 INFLUENZA 1 0.0000
588 THROMBOCYTOPENIA 1 0.0000
589 DEPRESSION 2 0.0000
590 LOSS OF CONSCIOUSNESS 1 0.0000
591 NEUTROPENIA 1 0.0000
592 ACUTE KIDNEY INJURY 1 0.0000
593 URTICARIA 1 0.0000
594 TOXICITY TO VARIOUS AGENTS 1 0.0000
595 ANAEMIA 1 0.0000
596 ERYTHEMA 1 0.0000
597 OVERDOSE 1 0.0000